| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_22f429ca185f60cee22e934c330ea0ac |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2800-522 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-9789
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-671
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-676
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-602
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-606
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-675
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-0212
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-445 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q19-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-9789
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-67 |
| filingDate |
2020-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cb355a551d53393fde9e248bfa02d60c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1f3cce612487a4d62bee04704b323a5a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_12430214702280b7c89c0cc3e59098ea |
| publicationDate |
2021-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2021006637-A1 |
| titleOfInvention |
Cosmetic composition comprising 5-benzylaminosalicylic acid derivative and local administration method thereof |
| abstract |
The present invention relates to a composition comprising: a 5-benzylaminosalicylic acid compound in chemical formula I or cosmetically acceptable salts thereof; and a cosmetically acceptable excipient suitable for local administration. The composition comprising the 5-benzylaminosalicylic acid compound in chemical formula I or cosmetically acceptable salts thereof can be used for reducing or alleviating human skin aging by means of antioxidant, anti-inflammatory and whitening actions on the skin. |
| priorityDate |
2019-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |